JOSEPH RICHARDS: Open Payments
NPI 1477835064 · SUNRISE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 11 payments from 9 companies in 2025. Trend: 2023 $244 · 2024 $568 · 2025 $986
Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| bioMerieux Inc | 2 | $173 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $138 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $117 |
| CSL Behring | 2 | $46 |
| Viatris Specialty LLC | 1 | $22 |
Products named: REJOYN, INGREZZA, EVENITY, JARDIANCE, XIFAXAN, Kerendia, Kcentra, YUPELRI.
Industry payments across FL — which companies pay providers there.
